You are switching to a website for another country and will be subject to the terms and policies therein. Products on that website may or may not be available or approved for your location. Please contact your CONMED representative if you have questions about the availability of products in your location. By continuing, you acknowledge and agree to the terms of this notice.
This page/product is not available or unable to be marketed to your region.
You are about to switch language.
You are about to be directed to a website maintained by another organization that is solely responsible for its content. As we cannot control the content, data security, or privacy practices of any third-party website, we encourage you to read the policies of every website you visit.
AirSeal®: Fact or Fiction
Published: 1/22/2025
2 min
FACT
-
OR
-
FICTION
AirSeal® is only for robotic-assisted laparoscopic surgery.
FICTION
AirSeal® is for every minimally invasive surgery in the abdominal and thoracic cavities for both adult and pediatric patients.
FACT
-
OR
-
FICTION
AirSeal® has been used to treat over 7.5 million patients.
FACT
AirSeal® is used in over 4,000 facilities in 80 countries to treat over 7.5 million patients.
FACT
-
OR
-
FICTION
High-flow conventional insufflation provides stability and improves patient outcomes.
FICTION
There is no evidence that suggests high-flow conventional insufflation improves stability or patient outcomes. AirSeal® is the only insufflation system backed by clinical data showing improved patient outcomes at low pressure.
There’s still more to AirSeal® than meets the eye. From its proprietary cannula design to its data-backed improvement of patient outcomes, AirSeal® is changing the insufflation game.